Company name
2022Founder
Atul Dandekar leads business development, partnering, portfolio management, and corporate strategy at Maze Therapeutics, which develops precision medicines informed by genetic insights. He previously held leadership roles in ophthalmology at Genentech and Roche and neuroscience at Novartis, and co-founded Ollin Biosciences.
CBO, Maze Tx and Co-founder, Ollin
Board Member
degrees in medicine and management
master’s in marketing management
Cosign details are not available yet.
More profile details are not available yet.